|
KMID : 0361020220660030192
|
|
Korean Journal of Otolaryngology - Head and Neck Surgery
2022 Volume.66 No. 3 p.192 ~ p.197
|
|
|
A Case of Complete Remission of Nasal Cavity Poorly Differentiated Carcinoma With Targeted Therapy, to Which Surgery and Concurrent Chemoradiotherapy Was Ineffective
|
|
Ryu Hyun-Tae
Jo Hyung-Dong
Pyo Su-Yeon
Kim Hyun-Jik
|
|
|
Abstract
|
|
|
|
Nasal cavity and paranasal sinus cancers comprise about 1% of all malignancies, and 5% ofhead and neck malignancy. Squamous cell carcinoma comprises more than half of nasal cavi-ty cancers. Treatment is determined by considering tumor size, location, staging, age, generalcondition, purpose of treatment, etc. Conventional therapy includes surgery, radiotherapy, andchemotherapy; however, for the locally advanced, recurrent, or metastatic cancer after con-ventional therapy, immunotherapy or targeted therapy are taken into consideration. Targettherapy attacks specific cancer cells directly, such as cancer cells with certain gene mutation,whereas immunotherapy attacks cancer cells indirectly, stimulating our own immune system,such as T-cell activity. Histologically poorly differentiated carcinomas are treated with sur-gery, radiotherapy, and sometimes chemotherapy, but 5-year survival rate is low due to fre-quent recurrence. Here, we present a case of successful targeted therapy applied to recurrentnasal cavity cancer after serial application of conventional therapies.
|
|
|
KEYWORD
|
|
|
Conventional therapy, Nasal cavity cancer, Targeted therapy
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
  
|
|